publication venue for
- Infliximab as a potential treatment for COVID-19. 2022
- Ethical challenges of prospective clinical trials during the COVID-19 pandemic. 2021
- The surviving sepsis controversy: a call to action for hospital medicine.. 16. 2018
- The rise of hospitalists: an opportunity for infectious diseases investigators.. 16. 2018
- Pulmonary infections and resistance to antibiotics: recent information. 2012
- Teixobactin: a novel anti-infective agent.. 17. 2018
- Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine. 2020
- Candidemia in the cancer patient: diagnosis, treatment, and future directions. 2018
- Containment strategies to address the expanding threat of multidrug-resistant Candida auris. 2017
- Drug development challenges and strategies to address emerging and resistant fungal pathogens. 2017
- Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting. 2012
- Hepatitis C virus infection: the new global epidemic. 2005
- Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. 2004
- Hepatitis C-HIV coinfection: current and future therapy. 2003
- Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease. 2006
- Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity. 2005